Genetic Technologies Limited (GENE)
NASDAQ: GENE · IEX Real-Time Price · USD
2.255
+0.005 (0.22%)
At close: May 3, 2024, 3:59 PM
2.350
+0.095 (4.21%)
After-hours: May 3, 2024, 6:48 PM EDT

Genetic Technologies Revenue

Genetic Technologies had revenue of $5.78M in the twelve months ending December 31, 2023. In the fiscal year ending June 30, 2023, Genetic Technologies had annual revenue of $5.99M with 26.95% growth.

Revenue (ttm)
$5.78M
Revenue Growth
+26.95%
P/S Ratio
1.80
Revenue / Employee
$96,268
Employees
60
Market Cap
10.39M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20235.99M1.27M26.95%
Jun 30, 20224.72M4.63M5,105.78%
Jun 30, 202190.64K83.84K1,232.38%
Jun 30, 20206.80K-11.12K-62.03%
Jun 30, 201917.92K-122.27K-87.22%
Jun 30, 2018140.19K-258.57K-64.84%
Jun 30, 2017398.76K-438.96K-52.40%
Jun 30, 2016837.71K-1.50M-64.23%
Jun 30, 20152.34M-2.77M-54.20%
Jun 30, 20145.11M-2.35M-31.49%
Jun 30, 20137.46M485.83K6.96%
Jun 30, 20126.98M-12.83M-64.78%
Jun 30, 201119.81M12.48M170.26%
Jun 30, 20107.33M-753.79K-9.32%
Jun 30, 20098.08M-6.89M-46.01%
Jun 30, 200814.97M2.48M19.83%
Jun 30, 200712.49M5.03M67.42%
Jun 30, 20067.46M1.97M35.86%
Jun 30, 20055.49M3.66M199.03%
Jun 30, 20041.84M-1.12M-37.80%
Jun 30, 20032.95M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ontrak 12.74M
Guardion Health Sciences 12.25M
BioCardia 477.00K
Nexalin Technology 110.75K
Bionomics 15.00K
Revenue Rankings